The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis

Clinical trial NCT04638517 · TERMINATED

Trial details

NCT number: NCT04638517
Sponsor: The University of Queensland
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Fibrosis Telomere Shortening Telomere Disease Dyskeratosis Congenita

Start date: 2021-09-07
Primary completion: 2025-01-16
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.